Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard......
The Union Home ministry has ordered a Central Bureau of Investigation (CBI) inquiry into the supply of substandard medicines in Delhi government hospitals and whether the drugs were also......
Around 7.4 per cent of Indians aged 60 and above are affected by dementia.This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase. Kindly......
Nearly one in every two medical prescriptions issued in India deviated from standard guidelines, with approximately a tenth showing 'unacceptable deviations', a study, conducted by a team of......
An international team, including scientists of Indian-origin, has identified 69 drugs and experimental compounds which may be effective in treating COVD-19. According to the researchers, some of......
Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval to market Fosinopril sodium tablets in the United States.The USFDA website on Monday said that the company had......
As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic......
Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid.Medications using these combinations are......
Ranbaxy Laboratories on Thursday launched a generic version of Prasugrel, used in treating heart diseases, from Daiichi Sankyo portfolio in India as part of strategy to launch drugs from the parent......
The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to industry sources.While this could pull the company......